{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:57:38Z","timestamp":1790798258884,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["201602855"],"award-info":[{"award-number":["201602855"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0766-1","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T23:24:51Z","timestamp":1480029891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ratio of apoB\/LDL: a potential clinical index for vascular cognitive impairment"],"prefix":"10.1186","volume":"16","author":[{"given":"Cheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association. Stroke. 2011;42:2672\u2013713.","journal-title":"Stroke"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"G Roman","year":"1993","unstructured":"Roman G, Takemici T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology. 1993;43:250\u201360.","journal-title":"Neurology"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain. 2013;136:2697\u2013706.","journal-title":"Brain"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-010-0718-6","volume":"120","author":"C Iadecola","year":"2010","unstructured":"Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010;120:287\u201396.","journal-title":"Acta Neuropathol"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.neuron.2011.07.013","volume":"71","author":"A Quaegebeur","year":"2011","unstructured":"Quaegebeur A, Lange C, Carmeliet P. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron. 2011;71:406\u201324.","journal-title":"Neuron"},{"key":"766_CR6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1212\/WNL.43.10.2159-a","volume":"43","author":"V Hachinski","year":"1993","unstructured":"Hachinski V, Bowler J. Vascular dementia. Neurology. 1993;43:2159\u201360.","journal-title":"Neurology"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(74)91496-2","volume":"2","author":"V Hachinski","year":"1974","unstructured":"Hachinski V, Lassen N, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2:207\u201310.","journal-title":"Lancet"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nrl.2011.12.014","volume":"30","author":"PL Rodr\u00edguez Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez Garc\u00eda PL, Rodr\u00edguez GD. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015;30:223\u201339.","journal-title":"Neurologia"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-Mental State\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1017\/S1041610209008941","volume":"21","author":"P Hancock","year":"2009","unstructured":"Hancock P, Larner AJ. Diagnostic utility of the informant questionnaire on cognitive decline in the elderly (IQCODE) and its combination with the Addenbrooke\u2019s cognitive examination-revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr. 2009;21:526\u201330.","journal-title":"Int Psychogeriatr"},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/gps.2639","volume":"26","author":"P Hancock","year":"2011","unstructured":"Hancock P, Larner AJ. Test Your Memory (TYM) test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976\u201380.","journal-title":"Int J Geriatr Psychiatry"},{"key":"766_CR13","first-page":"409","volume":"37","author":"J Durbin","year":"1950","unstructured":"Durbin J, Watson GS. Testing for serial correlation in least squares regression. I Bio28metrika. 1950;37:409\u201328.","journal-title":"I Bio28metrika"},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/1047-2797(92)90033-M","volume":"2","author":"WP Castelli","year":"1992","unstructured":"Castelli WP, Anderson K, Wilson PW, Levy D. The Framingham Study. Lipids and risk of coronary heart disease. Ann Epidemiol. 1992;2:23\u20138.","journal-title":"Ann Epidemiol"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","volume":"15","author":"KJ Williams","year":"1995","unstructured":"Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","volume":"68","author":"A Solomon","year":"2007","unstructured":"Solomon A, Kareholt I, Ngandu TBM, et al. Serum cholesterol changes after midlife and late-life cognition, twenty-one-year follow-up study. Neurology. 2007;68:751\u20136.","journal-title":"Neurology"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000231980","volume":"28","author":"A Solomon","year":"2009","unstructured":"Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer\u2019s and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;28:75\u201380.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/ageing\/afs193","volume":"42","author":"O Okusaga","year":"2013","unstructured":"Okusaga O, Stewart MC, Butcher I, et al. Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults. Age Ageing. 2013;42:306\u201311.","journal-title":"Age Ageing"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/archneur.64.1.103","volume":"64","author":"R Stewart","year":"2007","unstructured":"Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2007;64:103\u20137.","journal-title":"Arch Neurol"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plipres.2011.11.004","volume":"51","author":"MD Ledesma","year":"2012","unstructured":"Ledesma MD, Martin MG, Dotti CG. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog Lipid Res. 2012;51:23\u201335.","journal-title":"Prog Lipid Res"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15252\/emmm.201303711","volume":"6","author":"MG Martin","year":"2014","unstructured":"Martin MG, Ahmed T, Korovaichuk A, et al. Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents. EMBO Mol Med. 2014;6:902\u201317.","journal-title":"EMBO Mol Med"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1532-5415.2010.02739.x","volume":"58","author":"CA Reynolds","year":"2010","unstructured":"Reynolds CA, Gatz M, Prince JA, Berg S, Pedersen NL. Serum lipid levels and cognitive change in late life. J Am Geriatr Soc. 2010;58:501\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","volume":"64","author":"MM Mielke","year":"2005","unstructured":"Mielke MM, Zandi PP, Sjogren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689\u201395.","journal-title":"Neurology"},{"key":"766_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1463-1326.2007.00714.x","volume":"10","author":"M Andrikoula","year":"2008","unstructured":"Andrikoula M, McDowell IFW. The contribution of apoB and apoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab. 2008;10:271\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.numecd.2014.07.006","volume":"25","author":"T Du","year":"2015","unstructured":"Du T, Zhang J, Yuan G, et al. Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes. Nutr Metab Cardiovasc Dis. 2015;25:100\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12944-015-0101-7","volume":"14","author":"T Nomikos","year":"2015","unstructured":"Nomikos T. Panagiotakos D2,3, Georgousopoulou E, et al. Hierarchical modelling of blood lipids\u2019 profile and 10-year (2002\u20132012) all cause mortality and incidence of cardiovascular disease: the ATTICA study. Lipids Health Dis. 2015;14:108.","journal-title":"Lipids Health Dis"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12952-015-0026-8","volume":"14","author":"NM Bogari","year":"2015","unstructured":"Bogari NM, Abdel-Latif AM, Hassan MA, et al. No association of apolipoprotein B gene polymorphism and blood lipids in obese Egyptian subjects. J Negat Results Biomed. 2015;14:7.","journal-title":"J Negat Results Biomed"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1373\/clinchem.2012.196733","volume":"59","author":"TG Cole","year":"2013","unstructured":"Cole TG, Contois JH, Csako G, et al. Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2013;59:752\u201370.","journal-title":"Clin Chem"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jacl.2014.11.005","volume":"9","author":"SA Varvel","year":"2015","unstructured":"Varvel SA, Dayspring TD, et al. Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice. J Clin Lipidol. 2015;9:247\u201355.","journal-title":"J Clin Lipidol"},{"key":"766_CR30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-130443","volume":"36","author":"S Vikarunnessa","year":"2013","unstructured":"Vikarunnessa S, Weiner MF, Vega GL. LDL phenotype in subjects with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2013;36:571\u20135.","journal-title":"J Alzheimers Dis"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11910-007-0058-7","volume":"7","author":"RA Whitmer","year":"2007","unstructured":"Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep. 2007;7:373\u201380.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/archneurol.2011.670","volume":"69","author":"TM Himbergen van","year":"2012","unstructured":"van Himbergen TM, Beiser AS, Ai M, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol. 2012;69:594\u2013600.","journal-title":"Arch Neurol"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"316495","DOI":"10.1155\/2013\/316495","volume":"2013","author":"AM Enciu","year":"2013","unstructured":"Enciu AM, Popescu BO. Is there a causal link between inflammation and dementia? Biomed Res Int. 2013;2013:316495.","journal-title":"Biomed Res Int"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0014-5793(93)81176-Z","volume":"315","author":"N Reisfeld","year":"1993","unstructured":"Reisfeld N, Lichtenberg D, Dagan A, Yedgar S. Apolipoprotein B exhibits phospholipase A1 and phospholipase A2 activities. FEBS Lett. 1993;315:267\u201370.","journal-title":"FEBS Lett"},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.chom.2008.10.001","volume":"4","author":"MM Peterson","year":"2008","unstructured":"Peterson MM, Mack JL, Hall PR, Alsup AA, Alexander SM, Sully EK, et al. Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe. 2008;4:555\u201366.","journal-title":"Cell Host Microbe"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"e0125027","DOI":"10.1371\/journal.pone.0125027","volume":"10","author":"BO Elmore","year":"2015","unstructured":"Elmore BO. Triplett KD1, Hall PR1. Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing. PLoS One. 2015;10:e0125027.","journal-title":"PLoS One"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/hbm.22030","volume":"34","author":"VJ Williams","year":"2013","unstructured":"Williams VJ, Leritz EC, Shepel J, et al. Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp. 2013;34:1826\u201341.","journal-title":"Hum Brain Mapp"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1476-511X-13-175","volume":"13","author":"SH Wang","year":"2014","unstructured":"Wang SH, Huang Y, Yuan Y, et al. LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses. Lipids Health Dis. 2014;13:175.","journal-title":"Lipids Health Dis"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375\u201397.","journal-title":"J Lipid Res"},{"issue":"5","key":"766_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/00365510510025746","volume":"65","author":"A Babiker","year":"2005","unstructured":"Babiker A, Dzeletovic S, Wiklund B, et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. Scand J Clin Lab Invest. 2005;65(5):365\u201375.","journal-title":"Scand J Clin Lab Invest"},{"key":"766_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","volume":"45","author":"M Heverin","year":"2004","unstructured":"Heverin M, Bogdanovic N, Lutjohann D, et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer\u2019s disease. J Lipid Res. 2004;45:186\u201393.","journal-title":"J Lipid Res"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"184042","DOI":"10.1155\/2012\/184042","volume":"2012","author":"GL Bowman","year":"2012","unstructured":"Bowman GL, Kaye JA, Quinn JF. Dyslipidemia and blood-brain barrier integrity in Alzheimer\u2019s disease. Curr Gerontol Geriatr Res. 2012;2012:184042.","journal-title":"Curr Gerontol Geriatr Res"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00109-009-0488-6","volume":"87","author":"A Dodelet-Devillers","year":"2009","unstructured":"Dodelet-Devillers A, Cayrol R, van Horssen J, et al. Functions of lipid raft membrane microdomains at the blood\u2013brain barrier. J Mol Med (Berl). 2009;87:765\u201374.","journal-title":"J Mol Med (Berl)"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12987-015-0013-y","volume":"12","author":"N L\u00e9n\u00e1rt","year":"2015","unstructured":"L\u00e9n\u00e1rt N, Walter FR, Bocsik A, et al. Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment. Fluids Barriers CNS. 2015;12:17.","journal-title":"Fluids Barriers CNS"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1073\/pnas.0702170104","volume":"104","author":"BJ Spencer","year":"2007","unstructured":"Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A. 2007;104:7594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR46","doi-asserted-by":"publisher","first-page":"e16575","DOI":"10.1371\/journal.pone.0016575","volume":"6","author":"B Spencer","year":"2011","unstructured":"Spencer B, Marr RA, Gindi R, et al. Peripheral delivery of a CNS targeted, metalo-protease reduces a\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease. PLoS One. 2011;6:e16575.","journal-title":"PLoS One"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-016-0766-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T19:32:08Z","timestamp":1568575928000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0766-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0766-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"243"}}